What is LOPJLB’s current signal on NXTC?

LOPJLB’s latest quantitative signal on NextCure, Inc. (NXTC) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is NXTC in?

NextCure, Inc. (NXTC) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does NextCure, Inc. (NXTC) do?

NextCure, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative immunotherapies. Its core mission is to combat cancer and various other immune-related conditions by reactivating normal immune system function. The company's leading investigational compound, NC318, is currently in Phase II clinical trials, focusing on the treatment of advanced or metast…

Where is NextCure, Inc. based / listed?

NextCure, Inc. is based in US, listed on NASDAQ.

NextCure, Inc. (NXTC)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$7.18+5.90%Close

BUYRECOVERY · day 3

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $26M
Beta: 1.34
P/E (TTM): -0.54

Short % float: 9.44%
Days to cover: 1.9
SI change: +102.7%

1W: +41.06%
1M: -1.78%

vs SPY 1W: +39.90%
vs SPY 1M: -4.77%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Prediction markets

Company news